Revolutionary Concepts, Inc. (OTCMKTS:REVO) Worn Down Ahead of Weekend
Revolutionary Concepts, Inc. (OTCMKTS:REVO) already had its revolution, and met the end of the week deep into the red zone. REVO lost 8.1% to $0.0193, on rather hefty selling volumes of $1.06 million. At this low price, REVO quickly consumed the good news of the potential patenting of its visual tracking and security technology. And also, REVO is not giving any signs that the vague rumors of becoming a marijuana stock are true. Still, even a mention of that possibility may have contributed to the rise, as almost any penny stock company could restyle itself into a business related to cannabis. 
Now, REVO will also wait for three long days before taking a new direction in the shortened trading week. There is still no new PR or promotions, and it is easily seen how quickly the momentum is lost with this stock, as the good days came very fast. Despite the setback on Friday, investors’ forums show great optimism that REVO could indeed spread out its surveillance and security technologies.
While REVO has the weaknesses inherent to many OTC companies that spent a long time in development, the latest trades are more focused on its future potential, and now it is up to REVO to either fulfill the promises- or promise much more in new PR or even an email campaign. Otherwise, the financial filings show serious drawbacks:
- $4,799 cash
- $244,030 total assets
- $3.4 million total current liabilities
- No revenues
- $13.69 million accumulated net loss
How REVO will dig itself out of the hole of losses is unknown, and it is unknown if it could visit a better price range without additional publicity efforts.
Still, REVO develops a bit better than other sub-penny selections, many of which tanked very soon after the initial hype. Stocks in any way related to marijuana sometimes bubble up to the surface- but very few remain steadier selections.
Resource Ventures, Inc. (OTCMKTS:REVI) tripled its price in a short period, but now drifts at $0.004 on dwindling trading volumes. REVI also appropriated existing technology to the marijuana business, but so far the link is tentative and we have yet to see the results in earnings. REVI for now hangs on the promise of printing the “Hemp Nation Magazine”, a specialized publication created in a team with Hemp, Inc. (OTCMKTS:HEMP).
Health Sciences Group, Inc. (OTCMKTS:HESG) is now done, only keeping up the $0.0004 levels as a day-trading selection. The triple-zero rose with a very slim promise of being related to the cannabis sector.
For now, it is best to be very skeptical of novelty when it comes to marijuana stocks, as staple companies return, while a lot of tickers rose and fell without a trace- except a trace on investors’ fortunes.
